Table 1.

Cases reported in literature showing the e6a2 transcript

Diagnosis	Sex/age	Coexpression of other transcripts	Other molecular alterations	Treatment	References
CP - CML	M/41			BMT	Hochhaus et al. [2]
CP - CML	M/50			IFN-Ara C-- > BMT	Dupont et al. [30]
BC - CML	M/65			Imatinib	Schultheis et al. [6]
CP - CML	M/76			IFN	Colla et al. [31]
CML secondary to CMML	F/64		t(11;16)	Imatinib	Hayette et al. [32]
CP - CML	M/37	e1a2		Imatinib	Roti et al. [16]
Acute basophilic leukemia	M/71			Imatinib-Dauno-Ara C	Gregoire et al. [33]
ALL	F/29			G MALL 7/03-Imatinib-- > BMT	Burmeister et al. [34]
CP - CML	M/43			Imatinib	Breccia et al. [35]
AML	F/53			Imatinib-Ida-Ara C -- > BMT-Dasatinib	Ritchie et al. [22]
AML (M7)	F/53		del(18)(p10)	Imatinib-Ida-Ara C -- > Dasatinib-BMT	Corm et al. [23]
CP - CML	M/48			Imatinib-- > Dasatinib	Schnittger et al. [36]
CP - CML	M/48		t(7;9), ins(22;9)	Imatinib-- > BMT	Vefring et al. [17]
AP - CML	M/42			Imatinib -- > BMT-Dasatinib	Vefring et al. [17]
CP - CML	M/67			Imatinib	Popovici et al. [26]
CP - CML	F/18			Imatinib	Torres et al. [37]
AP - CML	M/57		trisomy 8	Imatinib	Beel et al. [18]
CP - CML	M/36	e1a2		Imatinib-Nilotinib -- > BMT	Langabeer et al. [15]
AP - CML	M/51			Imatinib-- > BMT	Rohon et al. [19]
BC – CML	M/48			Dasatinib	Zagaria et al. [14]
AML (M4)	F/55			Mitox-Ara C-Imatinib -- > BMT-Dasatinib-DLI	Harada et al. [21]
BC - CML	F/48		trisomy and tetrasomy 8	Dauno-Ara c-Imatinib -- > BMT	Crampe et al. [20]
AML secondary to CMML	M/58		DNMT3A RUNX1 SUZ12	3 + 7-Dasatinib-Nilotinib	Yao et al. [25]
AML secondary to myelofibrosis	M/80		JAK2-V617F	Hydroxyurea-valproic acid Dasatinib-Imatinib	Brattas et al. [38]